[go: up one dir, main page]

DK1984014T3 - Anvendelse af tpo-peptidforbindelser og farmaceutiske sammensætninger ved behandlingen af anæmi - Google Patents

Anvendelse af tpo-peptidforbindelser og farmaceutiske sammensætninger ved behandlingen af anæmi

Info

Publication number
DK1984014T3
DK1984014T3 DK06735131.2T DK06735131T DK1984014T3 DK 1984014 T3 DK1984014 T3 DK 1984014T3 DK 06735131 T DK06735131 T DK 06735131T DK 1984014 T3 DK1984014 T3 DK 1984014T3
Authority
DK
Denmark
Prior art keywords
anaemia
tpo
relations
peptide
treatment
Prior art date
Application number
DK06735131.2T
Other languages
English (en)
Inventor
Edward J Yurkow
Brian R Macdonald
Jeffery K Weis
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of DK1984014T3 publication Critical patent/DK1984014T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/196Thrombopoietin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52Cytokines; Lymphokines; Interferons
    • C07K14/524Thrombopoietin, i.e. C-MPL ligand
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
DK06735131.2T 2006-02-14 2006-02-14 Anvendelse af tpo-peptidforbindelser og farmaceutiske sammensætninger ved behandlingen af anæmi DK1984014T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2006/005322 WO2007094781A1 (en) 2006-02-14 2006-02-14 Use of tpo peptide compounds and pharmaceutical compositions in the treatment of anemia

Publications (1)

Publication Number Publication Date
DK1984014T3 true DK1984014T3 (da) 2014-09-15

Family

ID=37904365

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06735131.2T DK1984014T3 (da) 2006-02-14 2006-02-14 Anvendelse af tpo-peptidforbindelser og farmaceutiske sammensætninger ved behandlingen af anæmi

Country Status (18)

Country Link
EP (1) EP1984014B1 (da)
JP (1) JP2009526841A (da)
CN (1) CN101374540B (da)
AU (1) AU2006338308B2 (da)
BR (1) BRPI0621347B8 (da)
CA (1) CA2642389C (da)
CY (1) CY1115629T1 (da)
DK (1) DK1984014T3 (da)
EA (1) EA015562B1 (da)
ES (1) ES2516649T3 (da)
IL (1) IL193268A (da)
NI (1) NI200800216A (da)
NO (1) NO341872B1 (da)
NZ (1) NZ570124A (da)
PL (1) PL1984014T3 (da)
PT (1) PT1984014E (da)
SI (1) SI1984014T1 (da)
WO (1) WO2007094781A1 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10358423B4 (de) 2003-08-26 2006-09-21 Mühlbauer Ag Modulbrücken für Smart Labels
AU2009256465B2 (en) * 2008-06-03 2015-05-14 Janssen Pharmaceutica Nv TPO mimetic peptide for preventing hematological disorder associated with cancer treatment
JP6150374B2 (ja) * 2012-11-15 2017-06-21 国立大学法人弘前大学 放射線被ばく治療剤及び放射線被ばく治療方法
JP7481252B2 (ja) 2017-07-26 2024-05-10 ヤンセン ファーマシューティカ エヌ.ベー. 標的放射線治療誘発性血管完全性を保護する方法
AU2020211412A1 (en) 2019-01-25 2021-08-12 Janssen Pharmaceutica Nv Methods for mitigating liver injury and promoting liver hypertrophy, regeneration and cell engraftment in conjunction with radiation and/or radiomimetic treatments
EP3914281A1 (en) 2019-01-25 2021-12-01 Janssen Pharmaceutica NV Methods of enhancing protection against organ and vascular injury, hematopoietic recovery and survival in response to total body radiation/chemical exposure
CN113905754B (zh) 2019-01-25 2025-03-11 詹森药业有限公司 减轻起疱剂和腐蚀性气体毒性作用的方法
EP4408984A1 (en) 2021-10-01 2024-08-07 Janssen Pharmaceutica NV Methods of increasing progenitor cell production
WO2024095178A1 (en) 2022-11-01 2024-05-10 Janssen Pharmaceutica Nv Thrombopoietin mimetic for use in the treatment of acute liver failure

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995021626A1 (en) * 1994-02-14 1995-08-17 University Of Washington Methods for stimulating erythropoiesis using thrombopoietin
KR20050093759A (ko) * 2002-09-18 2005-09-23 오르토-맥네일 파마슈티칼, 인코퍼레이티드 혈소판 및 조혈 줄기세포의 생산을 증가시키는 방법
EP1675606B1 (en) * 2003-08-28 2017-04-05 Janssen Pharmaceuticals, Inc. Peptides and compounds that bind to thrombopoietin receptors

Also Published As

Publication number Publication date
IL193268A (en) 2015-02-26
NZ570124A (en) 2011-05-27
BRPI0621347A2 (pt) 2011-12-06
CN101374540A (zh) 2009-02-25
BRPI0621347B1 (pt) 2018-05-08
PL1984014T3 (pl) 2015-02-27
EP1984014B1 (en) 2014-08-06
AU2006338308A1 (en) 2007-08-23
NO20083928L (no) 2008-09-15
CY1115629T1 (el) 2017-01-04
PT1984014E (pt) 2014-11-13
AU2006338308B2 (en) 2012-11-01
IL193268A0 (en) 2009-02-11
EP1984014A1 (en) 2008-10-29
JP2009526841A (ja) 2009-07-23
NO341872B1 (no) 2018-02-12
WO2007094781A1 (en) 2007-08-23
NI200800216A (es) 2012-01-24
EA200870261A1 (ru) 2009-02-27
CA2642389A1 (en) 2007-08-23
BRPI0621347B8 (pt) 2021-05-25
CN101374540B (zh) 2013-03-06
HK1125055A1 (en) 2009-07-31
SI1984014T1 (sl) 2014-12-31
ES2516649T3 (es) 2014-10-31
CA2642389C (en) 2014-05-06
HK1129571A1 (en) 2009-12-04
EA015562B1 (ru) 2011-08-30

Similar Documents

Publication Publication Date Title
DK2653873T3 (da) Sammensætninger og anvendelser til behandling af multipel sklerose
DK1978947T3 (da) Nitrooxyderivater til anvendelse ved behandling af muskeldystrofier
SI2079760T1 (sl) Sestavki in metode za zdravljenje okužb
SI2084151T1 (sl) Substituirani dihidropirazoloni za zdravljenje kardiovaskularnih in hematoloških bolezni
ATE503784T1 (de) (meth)acrylat-/aspartatamin-heilmittel und beschichtungen und artikel damit
DK2185164T3 (da) Sammensætning og terapeutisk antitumorvaccine
DK1937824T3 (da) Sammensætninger af tRNA og anvendelser deraf
DK2124999T3 (da) Activin-actrii antagonister og anvendelser til behandling af anæmi
DK2155188T3 (da) Fremgangsmåder og sammensætninger til behandling af tilbagevendende kræft
EP1940423A4 (en) METHODS AND COMPOSITIONS OF TISSUE GENIUS
EP2096444A4 (en) MICROCHIP AND ANALYZER USING THEREOF
DK1883665T3 (da) Polylactidsammensætninger og anvendelser deraf
BRPI0905715A2 (pt) Composição farmacêutica e kit de componentes
IL197148A0 (en) Methods and compositions for the treatment of antibody mediated neuropathies
SI2046324T1 (sl) Zdravljenje in preventiva mukozitisa z derivati antocianidina
EP2079544A4 (en) ARSENIC ABSORBENT COMPOSITION AND METHODS OF USE
EP2079526A4 (en) COMPOSITIONS AND ITS USES IN THE TREATMENT OF WOUNDS
DK2043671T3 (da) Peptid og sammensætning deraf til anvendelse ved behandling af slagtilfælde med feber
DE602007000304D1 (de) Schützende und regenerierende Zusammensetzung
DK2063881T3 (da) Sammensætning og fremgangsmåde til virksom og sikker administration af halopyruvat til behandlingen af cancer
DK2069467T3 (da) Adskillende sammensætninger og fremgangsmåder til anvendelse
DK2235002T3 (da) 4-pyridinonforbindelser og anvendelse heraf til behandling af cancer
IL195272A0 (en) Methods and compositions for the treatment of viral infections
DK2034956T4 (da) Sammensætninger omfattende glycosaminoglycaner med lav viskositet og anvendelse af disse sammensætninger ved behandling af kronisk cystitis
DK2034999T3 (da) DHA-estere og anvendelse deraf i behandlingen og forebyggelsen af cardiovaskulære sygdomme